EMR vs HON: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

EMR is the larger of the two ($93.86B market cap): the incumbent the market prices for continued execution (20.86x forward earnings, beta 1.21). HON is the smaller challenger ($71.99B), priced similarly on forward earnings (23.00x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

EMR vs HON: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricEMRHONWhat it tells you
Market cap$93.86B$71.99BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E20.8623.00Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E34.9911.26Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.210.88Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range91% of range49% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book4.523.22How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how EMR and HON affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. EMR and HON share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined EMR and HON exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Emerson Electric (EMR) do?

Emerson Electric is a global industrial-technology company focused on automation, helping manufacturers and process industries run their plants more efficiently, safely, and reliably. Over the past several years Emerson has transformed itself from a diversified industrial conglomerate into a more focused automation pure-play, divesting legacy businesses like its commercial and residential climate-technologies unit and acquiring software and measurement assets. Its core products include process control systems, measurement and analytical instruments, valves and actuators, software for plant operations, and test and measurement equipment, much of it sold under brands like DeltaV, Rosemount, Fisher, AspenTech, and NI (National Instruments). Customers span energy, chemicals, life sciences, power, water, food and beverage, and discrete manufacturing. Emerson makes money by selling this hardware and software plus recurring service, software subscriptions, and aftermarket parts, with a meaningful share of revenue tied to keeping installed systems running. The shift toward higher-margin software and recurring revenue, anchored by AspenTech, is central to its strategy. Emerson is headquartered in St. Louis, Missouri.

Full EMR guide

What does Honeywell International (HON) do?

Honeywell, which now operates as Honeywell Technologies (Nasdaq: HON), describes itself as a global, pure-play automation company serving the building, industrial and process sectors through services, solutions and products, run on its Accelerator operating system and its Forge intelligence layer. It has more than 50,000 employees and decades of operating data from a global installed base. Its Building Automation business sells controls, sensors, fire and security systems for commercial buildings. Industrial Automation covers process control, sensing, warehouse automation and the productivity (barcode scanning) business, and the process-technology franchise licenses refining and petrochemical technology and supplies the equipment and services around it, such as its planned role at the Dangote refinery project in Kenya. Honeywell makes money from a mix of equipment sales, long-cycle projects, recurring service and growing software offerings.

Full HON guide

EMR vs HON: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • EMR drivers: Automation pure-play transformation; Software and recurring revenue.
  • HON drivers: Pure-play automation focus; Software and physical AI on the installed base.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Emerson's end markets are cyclical and tied to industrial capital spending, energy and chemical capex, and the global economy, so downturns can slow orders and revenue. For HON, as a standalone automation company, Honeywell is more exposed to construction activity, manufacturing capex and energy-sector spending than when aerospace aftermarket revenue cushioned results.

EMR or HON: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick EMR if you believe its drivers more; HON if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the EMR and HON guides.

EMR vs HON: the full fundamentals

EMR. Emerson closed near $162 on October 16, 2026, close to its 52-week high of ~$166 after a ~19% YTD gain, and trades at about 22 times forward earnings and ~17 times EV/EBITDA, a premium to the average industrial. The market is paying for the software-heavy mix, ~27% operating margins and steady beats. Consensus for the November 4 fiscal Q4 report is ~$1.85 EPS on ~$5.1 billion of revenue.

HON. Honeywell's headline numbers are hard to read because the June 2026 aerospace spin-off and a large Q2 gain sit inside the trailing figures, which is why the trailing P/E shows near 8x. On forward estimates the stock trades around 22x 2027 EPS of about $9.82, a multiple in line with quality automation peers. The Q3 report on October 22 (consensus EPS about $2.16 on revenue of about $5.0 billion) will give the first clean standalone quarter.

Headline figures (approximate, October 2026): EMR shows revenue (ttm) ~$18.6B, revenue growth (june 2026 qtr, yoy) ~+7%, operating margin ~27%, net income (ttm) ~$2.6B; HON shows revenue (ttm, includes aerospace until june) ~$38.1 billion, q2 2026 revenue (continuing operations) ~$5.2 billion, 2026 revenue (analyst consensus) ~$20.2 billion, operating margin ~20%.

The bottom line: EMR vs HON

EMR and HON are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined EMR and HON exposure against your real portfolio. It is not an investment adviser.

Wondering how EMR or HON fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Emerson Electric

Ask Walnut's AI anything about EMR and see how it fits what you own.

FAQ

What is the difference between EMR and HON?

+

Emerson Electric is a global industrial-technology company focused on automation, helping manufacturers and process industries run their plants more efficiently, safely, and reliably. Honeywell, which now operates as Honeywell Technologies (Nasdaq: HON), describes itself as a global, pure-play automation company serving the building, industrial and process sectors through services, solutions and products, run on its Accelerator operating system and its Forge intelligence layer. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is EMR or HON the better stock?

+

Neither is universally better. EMR is the larger incumbent; HON is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, EMR or HON?

+

On forward P/E (as of November 2026), EMR trades at 20.86x and HON at 23.00x, so EMR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both EMR and HON?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of EMR vs HON?

+

EMR: Emerson's end markets are cyclical and tied to industrial capital spending, energy and chemical capex, and the global economy, so downturns can slow orders and revenue. The transformation through large acquisitions like AspenTech and NI carries integration, execution, and valuation risk, and the company took on debt and complexity to fund deals (about $13.8 billion of debt against ~$2.2 billion of cash). Competition in automation and industrial software is intense, including from larger and lower-cost rivals. Foreign-exchange effects, supply-chain disruptions, and project delays can pressure results. After a ~19% run in 2026, the stock trades at about 36 times trailing and 22 times forward earnings, so expectations into the November 4 report are elevated, and the payoff from the software pivot must still prove out fully. HON: As a standalone automation company, Honeywell is more exposed to construction activity, manufacturing capex and energy-sector spending than when aerospace aftermarket revenue cushioned results. Earnings are expected to fall sharply in reported terms in 2026 (consensus of about $8.30 of EPS versus far higher prior-year figures that included aerospace), and the separation adds execution risk: stranded costs, new capital structures and a limited standalone reporting history. Debt of about $35 billion against about $9.2 billion of cash (latest reported figures, which straddle the spin) leaves the balance sheet a watch point. The productivity solutions (warehouse and barcode) business has shown cyclical softness, and analysts have been trimming price targets (Mizuho cut its target to $255 from $265 in October). Input costs, supply chains and currency swings also affect margins.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell EMR or HON; figures are approximate and dated (as of November 2026). Verify current data before investing.